Kyverna Therapeutics, Inc.KYTXNASDAQ
Loading
Gross Profit Growth AcceleratingAccelerating
Percentile Rank33
Studio
Year-over-Year Change

Year-over-year gross profit growth rate

Percentile
P33
Within normal range
vs 2Y Ago
-1x
Contraction
Streak
1 yr
Consecutive growthAccelerating
PeriodValue
2024-24.96%
2023-124.30%
202224.20%
20210.00%